Most Popular

1
[Exclusive] Korean military set to ban iPhones over 'security' concerns
2
Korean, Romanian leaders discuss defense tech, nuclear energy
3
[Graphic News] 77% of young Koreans still financially dependent
4
S. Korea calls on Japan to confront history amid Yasukuni Shrine visit
5
Yoon’s jailed mother-in-law excluded from latest parole list

6
Hybe and Min Hee-jin, CEO of Hybe sublabel Ador, lock horns
7
[Pressure points] Leggings in public: Fashion statement or social faux pas?
8
Yoo Jae-suk, Yoo Yeon-seok team up in 'Whenever Possible'
9
Aging population to drive down Korea's housing prices from 2040: experts
10
North Korea holds drills simulating nuclear counterattack against enemy

NewsletterSubscribe

Start your day with a roundup of key stories from The Korea Herald with news and comment on all that’s happening in Korea.

LegoChem Bio receives approval for superbacterial antibiotic test

By 윤정현

Published : Aug. 24, 2016 - 17:35

- Link copied

[DISCLOSURE] LegoChem Biosciences (141080) announced on Aug. 24 that it has obtained approval from the Ministry of Food and Drug Safety for a phase I clinical study of LCB01-0371, an injectable antibiotic that targets superbacteria.
The company added that oral medication is currently undergoing a phase II clinical study and will be later developed in the form of injection.

By Yun Jeong-hyeon (clareyun@heraldcorp.com)

LegoChem Bio receives approval for superbacterial antibiotic test

More from Headlines